Gossamer Bio Inc (GOSS)
0.67
-0.04
(-5.41%)
USD |
NASDAQ |
Apr 25, 16:00
0.6757
+0.01
(+0.85%)
After-Hours: 20:00
Gossamer Bio Price to Book Value: 2.428 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.546 |
| April 23, 2024 | 2.651 |
| April 22, 2024 | 2.670 |
| April 19, 2024 | 2.817 |
| April 18, 2024 | 2.897 |
| April 17, 2024 | 2.947 |
| April 16, 2024 | 2.950 |
| April 15, 2024 | 3.084 |
| April 12, 2024 | 3.217 |
| April 11, 2024 | 3.477 |
| April 10, 2024 | 3.593 |
| April 09, 2024 | 3.594 |
| April 08, 2024 | 3.881 |
| April 05, 2024 | 3.702 |
| April 04, 2024 | 3.845 |
| April 03, 2024 | 3.989 |
| April 02, 2024 | 4.133 |
| April 01, 2024 | 4.564 |
| March 28, 2024 | 4.241 |
| March 27, 2024 | 4.205 |
| March 26, 2024 | 4.420 |
| March 25, 2024 | 4.708 |
| March 22, 2024 | 4.852 |
| March 21, 2024 | 4.744 |
| March 20, 2024 | 4.852 |
| Date | Value |
|---|---|
| March 19, 2024 | 4.996 |
| March 18, 2024 | 4.960 |
| March 15, 2024 | 5.247 |
| March 14, 2024 | 5.031 |
| March 13, 2024 | 5.139 |
| March 12, 2024 | 5.031 |
| March 11, 2024 | 4.816 |
| March 08, 2024 | 4.960 |
| March 07, 2024 | 4.996 |
| March 06, 2024 | 5.427 |
| March 05, 2024 | 5.211 |
| March 04, 2024 | 5.211 |
| March 01, 2024 | 4.960 |
| February 29, 2024 | 5.067 |
| February 28, 2024 | 4.888 |
| February 27, 2024 | 4.420 |
| February 26, 2024 | 4.561 |
| February 23, 2024 | 4.668 |
| February 22, 2024 | 4.166 |
| February 21, 2024 | 4.381 |
| February 20, 2024 | 4.525 |
| February 16, 2024 | 3.878 |
| February 15, 2024 | 3.699 |
| February 14, 2024 | 3.474 |
| February 13, 2024 | 3.401 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.031
Minimum
Oct 24 2023
25.31
Maximum
Apr 08 2022
5.365
Average
2.843
Median
Apr 23 2020
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 18.77 |
| TG Therapeutics Inc | 13.38 |
| Replimune Group Inc | 0.8970 |
| 89bio Inc | 1.467 |
| Moderna Inc | 2.935 |
Price to Book Value Related Metrics
| Price | 0.67 |
| Earnings Yield | -196.8% |
| Market Cap | 151.14M |